News
Clinical Trials in India have gained global attention for their rapid growth, world-class infrastructure, and access to a diverse patient population. With increasing support from regulatory bodies and ...
Experts emphasize the need for enhanced clinical trial infrastructure in community oncology to ensure equitable access to ...
15h
Vietnam Investment Review on MSNInnovent to Present Promising Phase 2 Data for Breakthrough Eye Drug IBI302 at ARVO 2025A potential game changer in the treatment of retinal disease, the novel dual-target drug shows encouraging results.
SAN ANTONIO, May 1, 2025 /PRNewswire/ -- Summit Clinical Research, LLC ("Summit"), a leading ... of key senior leaders to drive the next phase of Summit's growth. Dr. Naim Alkhouri, MD, FAASLD ...
TFS HealthScience (TFS), a leading global Contract Research Organization (CRO), is deepening its collaboration with ...
Ingelheim, Germany, May 6, 2025 - Boehringer Ingelheim today announces the start of the JADE Phase II clinical study (NCT06769048), investigating the efficacy and safety of BI 1584862 as a potential ...
ImmunoGenesis, a clinical-stage biotechnology company developing innovative, science-driven immune therapies, and Cancer ...
KRAS-targeted therapies, including daraxonrasib and zoldonrasib, show promise in overcoming resistance in cancer treatment, ...
Vertex Pharmaceuticals is pressing pause on a phase 1/2 cystic fibrosis (CF) trial over a tolerability issue, while reporting ...
A pioneering clinical study found that pairing vagus nerve stimulation (VNS) with traditional therapy eliminated PTSD ...
U.S. pharmaceutical companies are increasingly licensing new drugs from China. Former FDA Commissioner Scott Gottlieb ...
Dr. Scott T. Tagawa discusses what patients with prostate cancer should know about the potential benefits and risks of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results